Bacterial cell membrane and intracellular enzymes

The term “bacterial cell membrane and intracellular enzymes” encompasses two major categories of antibacterial drug targets. The **bacterial cytoplasmic (plasma) membrane** is a phospholipid bilayer essential for maintaining the cell’s internal environment, mediating energy production, nutrient uptake, and signal transduction[1][3][5][6]. **Intracellular enzymes** include all bacterial enzymes operating inside the cytoplasm, such as those for DNA replication, protein biosynthesis, energy metabolism, and cell wall assembly[7]. Many antibacterial drugs act by disrupting membrane integrity or by specifically inhibiting essential bacterial enzymes, leading to cell death or growth inhibition[4][5]. Because this entry does not represent a single molecule or well-defined target, it is considered *overly broad* and *non-specific* for inclusion as a canonical target entry in structured databases. This broadness makes it necessary to map either to more precise membrane proteins (e.g., penicillin-binding protein 2, DNA gyrase) or to use terms like “bacterial cell membrane (class)” or “bacterial intracellular enzyme (class)” in structured systems.

Other names

bacterial plasma membranebacterial cytoplasmic membranebacterial inner membranebacterial enzymesinternal bacterial enzymes

Cell membrane: disrupt membrane integrity, alter permeability, depolarize membrane potential, create pores, inhibit cell wall precursor synthesis. Enzyme: inhibit essential bacterial metabolic enzymes (e.g., DNA gyrase, RNA polymerase, transpeptidase/penicillin-binding proteins), block protein synthesis, block nucleotide synthesis.